CAR-M-targeting-HER2 has specific phagocytosis capacity in vitro and murine breast cancer models whose immunosuppressive microenvironment could be improved in a HER2-dependent way [27, 50]. The gene discussed is ERBB2; the disease is breast carcinoma.